Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2005
04/13/2005EP0774971B1 Synthetic peptide inhibitors of hiv transmission
04/13/2005EP0741782B1 Methods using eaa3 or eaa4 receptors
04/13/2005EP0728210B1 Thrombin mutants
04/13/2005EP0689609B2 Process for typing hla-b using specific primers and probes sets
04/13/2005CN1606627A Corn processing method and useful transgenic plant therein
04/13/2005CN1606626A Novel alkaline protease from bacillius sp. (DSM 14390) and washing and cleaning products comprising said novel alkaline protease
04/13/2005CN1606625A HIV-1 subtype isolate regulatory/accessory genes, and modifications and derivatives thereof
04/13/2005CN1606624A Vaccines
04/13/2005CN1606623A Production of stilbenes in transgenic plants and the method of producing thereof
04/13/2005CN1606622A Method of detecting and quantifying hemolysin-producing bacteria by overwhelmingly detecting and quantifying thermostable hemolysin-related genes tdh-related hemolysin genes of food poisoning bacteria
04/13/2005CN1606621A Method for collecting and using nuclear mRNA
04/13/2005CN1606619A Novel alkaline protease from bacillus gibsonii (DSM 14391) and washing and cleaning agents containing said novel alkaline protease
04/13/2005CN1606618A Novel alkali protease formed by bacillus gibsonii (DSM 14393) and washing and cleaning agents containing said novel alkali protease
04/13/2005CN1606617A Alleles of the siga gene from coryneform bacteria
04/13/2005CN1606616A Method for the recovery and purification of poxviruses from infected cells using high pressure homogenisation
04/13/2005CN1606570A A fusion protein suitable to highly effective expression and production method thereof
04/13/2005CN1606569A Human antibodies that have mn binding and cell adhesion-neutralizing activity
04/13/2005CN1606568A Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor
04/13/2005CN1606567A Antimicrobial polypeptides from pseudoplectania nigrella
04/13/2005CN1606565A Nucleic acids encoding recominant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses
04/13/2005CN1606475A Manufacturing process for array plate assembly
04/13/2005CN1606456A Restricted expression lentiviral vectors
04/13/2005CN1606453A Cripto blocking antibodies and uses thereof
04/13/2005CN1606451A Remedies and/or preventives for conformational diseases
04/13/2005CN1605629A Non-structural protein gene 3ABC of foot-and-mouth disease virus and its preparation and use
04/13/2005CN1605628A Human source anti-hepatitis A virus gene engineering antibody from CHO cell
04/13/2005CN1605592A Protease resistant mutein of human ciliary neurotrophic factor and its preparation and use
04/13/2005CN1605591A Labelled molecule capable of identifying reactive astrocytes and use thereof
04/13/2005CN1605589A PC-1 gene promoter and its application
04/13/2005CN1196797C Diagnostics and therapeutics for glaucoma
04/13/2005CN1196796C Vessel for blood sampling
04/13/2005CN1196792C New escherichia coli host/vector system based on antibiotic free selection by conplementation of auxotrophy
04/13/2005CN1196791C Psudomonas exotoxin-myelin basic protein chimeric proteins
04/13/2005CN1196790C Phosphoenolpyruvate carboxylase, its encoding gene and the application of the gene
04/13/2005CN1196789C Modified cytochrome P450 monooxygenases
04/13/2005CN1196788C Assembly of wild-type and chimeric influenza virus-like particles (VLPS)
04/13/2005CN1196787C Virulence genes and proteins and their use
04/13/2005CN1196786C Methods for preventing graft rejection in transplantation and for producing universal gene therapy host cell
04/13/2005CN1196785C Beta-amyloid peptdie-binding proteins and polynucleotides encoding the same
04/13/2005CN1196784C Promoter of human endoglin gene and its use
04/13/2005CN1196780C Novel methods for rescue of RNA viruses
04/13/2005CN1196735C Process for making fluorinated polymer adsorbent particles
04/13/2005CN1196712C Human like collagen and production method thereof
04/13/2005CN1196495C Mutant human CD80 and compositions and methods of making and using the same
04/13/2005CN1196474C Liposome-entrapped DNA oral vaccines
04/12/2005US6879713 Meiotic spindle imaging in oocytes and uses therefor in in vitro fertilization
04/12/2005US6878861 Acyl coenzyme A thioesterases
04/12/2005US6878860 Comprises antisense nucleotides sequences transformed and expressed in tomato for controlling flowering; gene expression inhibition and tissue engineering
04/12/2005US6878859 Transforming target legume plant with a DNA encoding isoflavone O-methyltransferase, to form a transgenic plant which exhibits increased levels of at least one 4'-O-methylated isoflavonoid compound
04/12/2005US6878858 Animal model for use as tool in the diagnosis and treatment of nervous system disorders
04/12/2005US6878818 Modified ubiquitin regulatory system
04/12/2005US6878817 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
04/12/2005US6878815 Heteropolymeric triplexes containing watson-crick triplets
04/12/2005US6878813 Elastase-resistant antithrombin III (ATIII) for treating blood clotting disorders
04/12/2005US6878812 Nucleotide sequences coding enzymatic polypeptide for use in treatment of inflammation and cancer
04/12/2005US6878810 Zace1: a human metalloenzyme
04/12/2005US6878809 Rad23 genes and uses thereof
04/12/2005US6878808 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof
04/12/2005US6878807 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/12/2005US6878805 Peptide-conjugated oligomeric compounds
04/12/2005US6878692 Nucleotide sequences coding apoptosis protein for use in the treatment of autoimmune diseases and cancer
04/12/2005US6878549 Generating expression vector for use as gene transfer tool
04/12/2005US6878547 Antisense oligonucleotides against tenascin for treating vitiligo
04/12/2005US6878546 Activating fetal nucleus; obtain cells, separate nucleus, incubate with egg extract, monitor nuclear activity
04/12/2005US6878544 Retinal cell lines with extended life-span and their applications
04/12/2005US6878542 Using fluorescence-activated cell sorting to separate and recover mammlian progenitor cells
04/12/2005US6878541 Papilloma pseudo-virus and preparation
04/12/2005US6878536 Phosphoriboxyl-pyrophosphate synthetase polypeptide
04/12/2005US6878533 Enzymatic activity for use in the biosynthesis of lysine for use in foods
04/12/2005US6878531 Using mutagenic primers and polymerase chain reaction for controlled mutation in nucleotide sequences; proteomics
04/12/2005US6878529 Compounds for the treatment of sexual dysfunction
04/12/2005US6878527 Modified proteins
04/12/2005US6878526 Treating cancer
04/12/2005US6878525 Peptide leukotriene receptor
04/12/2005US6878517 Multispecies food testing and characterization organoleptic properties
04/12/2005US6878516 Identifying protein and regulatory sequences which maintain bacterial; using antibiotics to control microorganismal infections; bactericides; microbiocides
04/12/2005US6878376 Modulate immunology response
04/12/2005US6878372 Methods of preventing and treating flavivirus infection in animals
04/12/2005CA2417135C Chimeric pre-activated transcription factors
04/12/2005CA2332628C Seed-preferred promoters
04/12/2005CA2306634C Suspension packing cell lines for retrovirus vectors
04/12/2005CA2274245C Sensors for electrically sensing binding events for supported molecular receptors
04/12/2005CA2267994C Truncated platelet-activating factor acetylhydrolase
04/12/2005CA2250704C Glial cell line-derived neurotrophic factor receptor
04/12/2005CA2209991C Nucleic acid amplification oligonucleotides and probes to lyme disease associated borrelia
04/12/2005CA2113813C Immunoglobulin variants for specific fc epsilon receptors
04/12/2005CA2086672C Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
04/12/2005CA2074825C Chimeric chains for receptor-associated signal transduction pathways
04/12/2005CA1341479C Hybrid single-chain plasminogen activators
04/08/2005CA2445743A1 Methods for modulating neuronal responses
04/07/2005WO2005031362A2 Novel antibacterial agents and methods of identifying and utilizing same
04/07/2005WO2005031002A2 Synthetic lethal screen using rna interference
04/07/2005WO2005030999A1 Methods to detect lineage-specific cells
04/07/2005WO2005030994A1 Cells and methods useful in characterising the immunotoxic activity of xenobiotic substances
04/07/2005WO2005030992A2 Method for the diagnosis/prognosis of neuroblastoma
04/07/2005WO2005030983A2 Amplification of polynucleotides by rolling circle amplification
04/07/2005WO2005030982A2 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs
04/07/2005WO2005030971A1 Modified vaccinia virus ankara (mva) mutant and use thereof
04/07/2005WO2005030970A2 Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances
04/07/2005WO2005030969A1 Method for mass production of human follicle stimulating hormone